Dahlen K, Epstein D L, Grant W M, Hutchinson B T, Prien E L, Krall J M
Arch Ophthalmol. 1978 Dec;96(12):2214-8. doi: 10.1001/archopht.1978.03910060516009.
Twenty-two patients with open-angle glaucoma were given weekly courses of methazolamide at different dosages. Mean intraocular pressure reductions of 3.3, 4.3, and 5.6 mm Hg were achieved at dosages of 25 mg, 50 mg, and 100 mg of methazolamide every eight hours, respectively. Maximal intraocular pressure lowering was still present nine to ten hours after administration. The mean reduction in outflow pressure for all eyes receiving a daily dosage of 300 mg was only 31%, but this included eyes (17% of the total) that demonstrated less than 13% reduction in outflow pressure, despite similar methazolamide serum levels. Eight patients subsequently received acetazolamide, 250 mg four times a day for a week. The effect of this dosage of acetazolamide on pressure was between the effects of 50 and 100 mg of methazolamide three times daily.
22例开角型青光眼患者接受了不同剂量的甲醋唑胺每周疗程治疗。每8小时分别给予25毫克、50毫克和100毫克甲醋唑胺时,平均眼压降低幅度分别为3.3、4.3和5.6毫米汞柱。给药后9至10小时仍存在最大眼压降低效果。所有接受每日300毫克剂量治疗的眼睛,其流出压平均降低仅31%,但这包括一些眼睛(占总数的17%),尽管甲醋唑胺血清水平相似,但其流出压降低幅度小于13%。8例患者随后接受了乙酰唑胺治疗,每天4次,每次250毫克,持续一周。该剂量的乙酰唑胺对眼压的影响介于每日3次服用50毫克和100毫克甲醋唑胺的效果之间。